Merit Medical Systems announced that it has received approval from the Chinese Food and Drug Administration to market Merit's Aero Tracheobronchial Stent System. The approval is for a period of five years and includes the "over-the-wire" system as well as the "direct visualization" system. The approval covers 33 catalog items. The product licenses are owned and maintained by Merit and will be distributed by a select group of dealers with support from Merit's marketing and clinical group, the company said.
- Health Care Industry
- Merit Medical Systems